SI-BONE, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
SIBN$25.10-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders' Equity
(In thousands, except share amounts)
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balances as of December 31, 2022 | 34,731,577 | $3 | $455,172 | $232 | $(357,105) | $98,302 |
| Issuance of common stock from public offerings, net of underwriting discounts, commissions and offering costs | 4,068,497 | 1 | 83,671 | — | — | 83,672 |
| Issuance of common stock upon exercise of stock options, net of shares withheld | 698,627 | — | 4,386 | — | — | 4,386 |
| Issuance of common stock related to employee stock purchase plan | 178,918 | — | 2,191 | — | — | 2,191 |
| Issuance of common stock upon vesting of restricted stock units | 993,077 | — | — | — | — | — |
| Issuance of common stock upon exercise of warrant, net of shares withheld | 22,603 | — | — | — | — | — |
| Stock-based compensation | — | — | 24,057 | — | — | 24,057 |
| Foreign currency translation | — | — | — | (63) | — | (63) |
| Net unrealized gain on marketable securities | — | — | — | 166 | — | 166 |
| Net loss | — | — | — | — | (43,336) | (43,336) |
| Balances as of December 31, 2023 | 40,693,299 | 4 | 569,477 | 335 | (400,441) | 169,375 |
| Issuance of common stock upon exercise of stock options, net of shares withheld | 143,685 | — | 570 | — | — | 570 |
| Issuance of common stock related to employee stock purchase plan | 176,787 | — | 2,154 | — | — | 2,154 |
| Issuance of common stock upon vesting of restricted stock units | 1,072,706 | — | — | — | — | — |
| Stock-based compensation | — | — | 25,869 | — | — | 25,869 |
| Foreign currency translation | — | — | — | (117) | — | (117) |
| Net unrealized gain on marketable securities | — | — | — | 26 | — | 26 |
| Net loss | — | — | — | — | (30,913) | (30,913) |
| Balances as of December 31, 2024 | 42,086,477 | 4 | 598,070 | 244 | (431,354) | 166,964 |
| Issuance of common stock upon exercise of stock options, net of shares withheld | 205,722 | — | 1,169 | — | — | 1,169 |
| Issuance of common stock related to employee stock purchase plan | 192,350 | — | 2,207 | — | — | 2,207 |
| Issuance of common stock upon vesting of restricted stock units | 1,161,888 | — | — | — | — | — |
| Issuance of common stock upon exercise of warrant, net of shares withheld | 694 | — | — | — | — | — |
| Stock-based compensation | — | — | 25,524 | — | — | 25,524 |
| Foreign currency translation | — | — | — | 559 | — | 559 |
| Net unrealized gain on marketable securities | — | — | — | 13 | — | 13 |
| Net loss | — | — | — | — | (18,904) | (18,904) |
| Balances as of December 31, 2025 | 43,647,131 | $4 | $626,970 | $816 | $(450,258) | $177,532 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.